Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes

NCT01223196 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Pioglitazone
DRUG: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio